Precise testing for polycystic ovary syndrome (PCOS)

Test indexes: testosterone, dehydroepiandrosterone sulfate, 17α- hydroxyprogesterone, dihydrotestosterone, dehydroepiandrosterone, cortisol, androstenedione, 11- deoxycortisol and 21- deoxycortisol

Polycystic ovary syndrome (PCOS)

In women of reproductive age, PCOS is a prevalent endocrine and metabolic condition characterized by chronic anovulation (ovulation dysfunction or loss) and hyperandrogenemia (excess male hormone production in women). The principal clinical manifestations are an irregular menstrual cycle, infertility, excessive hair growth and/or acne. It is the most prevalent endocrine disorder among women. PCOS has numerous clinical phenotypes, and the etiology is unclear at present. PCOS often exhibits family clustering phenomenon, suggesting that there are hereditary factors.

The prevalence of PCOS ranges between 5% to 10%. Using the statistics of China's about 350 million women of childbearing age, there are nearly 20 million PCOS patients in China. PCOS is an important risk factor for type II diabetes, cardiovascular disease, gestational diabetes mellitus, pregnancy-induced hypertension syndrome, and endometrial cancer.

Indicated for:

• People with a family history of PCOS.

• People with a previous history of PCOS.

• Women with irregular menstrual cycle, infertility, excessive hair growth, acne, and other manifestations.

• Patients with PCOS who are on therapy and need to monitor the effects of treatment.